Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The conclusion is that sex education should encourage critical thinking and be open to new scientific perspectives.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Retinoic acid affects male and female muscle energy use and function differently.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

DSDs are birth conditions causing unusual sex development, managed with personalized care and sometimes surgery, but still lack a standard treatment approach.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Sex hormones affect brain cells differently in males and females.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Finasteride may cause lasting sexual side effects, but more research is needed.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Regulating certain sex hormones may help delay facial aging.